InsidersTradesSigma
Marinus Pharmaceuticals, INC.: directors' dealings · United States · SEC (Form 4)
SEC:marinus-pharmaceuticals-inc-9e0966US·SEC (Form 4)Mcap 777.5Bn€Technology
Explore the full directors' dealings record of Marinus Pharmaceuticals, INC., a listed equity based in United States. Shares trade on US US, under the authority of SEC (Form 4). Operating in the Technology sector, Marinus Pharmaceuticals, INC. has recorded 4 reports. Market capitalisation: €777.5bn. The latest transaction was reported on 26 May 2022 — Attribution. Among the most active insiders: Hulihan Joseph. Every trade is accessible without an account.
4
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended August 2025 · cache
689.25 €
Analyst consensus
41 analystsStrong buy
249.00 €Target 584.24 €(-15%)1000.00 €
Income statement
Revenue37.38 Bn€
Gross profit14.87 Bn€40% margin
Net income8.54 Bn€41.5% margin
Valuation
PER (trailing)32.6x
PER (forward)6.7x
P/Book10.7x
Beta1.92
Balance sheet & cash
Market cap777.51 Bn€
Total debt15.28 Bn€
Free Cash Flow1.67 Bn€
Debt / Equity15%
Profitability & ownership
ROE39.8%
ROA20.1%
% insiders0.3%
% institutions81.1%
Last declaration on 26 May 2022
Declarations4 total
Executives◆Grant17SEC
07,718 shares0
Common Stock
SEC:0001104659-22-065241:0·
Executives◆Grant17SEC
05,790 shares0
Common Stock
SEC:0001104659-22-065315:0·
Executives◆Grant25SEC
07,448 shares0
Common Stock
SEC:0001104659-22-065237:0·
Executives◆Grant28SEC
019,305 shares0
Common Stock
SEC:0001104659-22-065240:0·
4 of 4 declarations